Verbatim response from Perplexity
Compounded oral GLP-1 drops and tablets generally do not work, as there is no published human evidence proving they cause meaningful weight loss, whereas FDA-approved oral tablets (like Rybelsus, the new Wegovy pill, and orforglipron) do work and produce results comparable to injections.
Compounded Drops vs. Tablets: The Critical Distinction
The effectiveness depends entirely on whether the product is FDA-approved or compounded (unregulated).
| Feature | Compounded Oral Drops/Tablets | FDA-Approved Oral Tablets |
|---|---|---|
| Do they work? | No proven efficacy. No human studies demonstrate they cause weight loss [1][3][6]. | Yes. Clinical trials show 9–13.6% body weight loss, comparable to injections [10][15]. |
| Formulation | Sublingual drops, patches, gummies, or low-dose orally disintegrating tablets (ODTs) [1][12]. | High-dose pills (e.g., 25 mg semaglutide) designed to overcome poor gut absorption [15]. |
| Safety/Quality | Unregulated. FDA does not review for safety, quality, or content; risks of inconsistency are high [2][5][7]. | Regulated. Tested in large trials for safety and effectiveness; consistent dosing [3][6]. |
| Recommendation | Avoid. Experts advise against them due to ineffectiveness and safety risks [1][3][5]. | Recommended. A practical choice for those avoiding needles, with only a "modest edge" for injections [3][10]. |
Why Compounded Drops Fail While Approved Pills Work
- Bioavailability Issues: GLP-1 molecules are difficult for the body to absorb orally. Compounded drops and patches have unknown absorption rates and lack the specific chemical carriers needed to survive stomach acid [4][15].
- High Dosing in Approved Pills: FDA-approved pills use very high doses (e.g., 25 mg) to compensate for the fact that only 0.4%–1% of the drug is absorbed after digestion [15]. Compounded versions often lack this precise high-dose formulation.
- No Clinical Data: There are zero peer-reviewed clinical trials for compounded semaglutide drops, patches, or nasal sprays [2][4]. In contrast, the Wegovy pill (25 mg) resulted in an average 13.6% weight loss in trials, very close to the 15% seen with the injection [10].
Which Brand/Service to Choose
If you want an effective oral GLP-1, you must choose an FDA-approved prescription:
- Rybelsus (oral semaglutide): The first approved oral option for diabetes; shown to lose ~9 lbs in 26 weeks [15].
- Wegovy (oral semaglutide, 25 mg): The new FDA-approved weight-loss pill; trials showed 13.6% body weight loss [10].
- Foundayo (oral orforglipron): A newer non-peptide oral GLP-1; trials showed ~12% body weight loss [10][15].
Avoid any clinic or online service selling "compounded GLP-1 drops," "patches," or "gummies" for weight loss, as these are unproven and potentially fraudulent [1][12]. The American Diabetes Association explicitly recommends against using non-FDA-approved compounded GLP-1 products [5].